LITHOTABS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lithotabs, and what generic alternatives are available?
Lithotabs is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in LITHOTABS is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lithotabs
A generic version of LITHOTABS was approved as lithium carbonate by HIKMA on January 29th, 1982.
Summary for LITHOTABS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 133 |
| Clinical Trials: | 3 |
| Patent Applications: | 2,019 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LITHOTABS at DailyMed |
Recent Clinical Trials for LITHOTABS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Paolo Caimi, MD | Phase 1 |
| National Cancer Institute (NCI) | Phase 1 |
| National Cancer Institute (NCI) | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for LITHOTABS
US Patents and Regulatory Information for LITHOTABS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | LITHOTABS | lithium carbonate | TABLET;ORAL | 016980-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
